Iluzanebart Antibody
Iluzanebart is a human monoclonal IgG1 agonist antibody targeting TREM2, designed to enhance microglial function and survival. It serves as a research tool for modeling microglial dysfunction in neurodegenerative diseases like CSF1R-ALSP, applicable in both in vitro and in vivo experimental systems.
Product Specifications
Target
Serine/threonin kinase, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Metabolism Research
Concentration
7.68 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.90 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog